Clinical Trial Update: High Dose Flu Vaccine in Treating Children Who Have Undergone Donor Stem Cell Transplant [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a high-dose influenza vaccine in children who have undergone donor stem cell transplantation; the study has completed with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Neoplasm

Drugs mentioned

• Influenza vaccine, high-dose (high-dose influenza vaccine)

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Hematopoietic Cell Transplantation Recipient, Malignant Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2022-04-14